TDX ETHOSUXIMIDE— 510(k) K850174

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K850174 for TDX ETHOSUXIMIDE, Substantially Equivalent on 1985-02-06. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code DLF
Advisory panel: Clinical Toxicology
Date received: 1985-01-17
Decision date: 1985-02-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.